XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Product
Revenue by product for the periods indicated were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2025202420252024
CHEMOSAT$1,310 $1,163 $4,727 $3,490 
HEPZATO KIT19,253 10,037 59,776 18,615 
Total revenue$20,563 $11,200 $64,503 $22,105 
Schedule of Revenue and Accounts Receivable Concentrations
The Company’s total percentage of revenue and accounts receivable balances were comprised of the following concentrations from its largest customers, based on whose revenue and/or accounts receivable concentration is greater than 10% of total revenue or total accounts receivable in the periods disclosed below:
For the nine months ended and as of September 30, 2025
% of Revenue% of Accounts Receivable
Customer 113.9 %15.0 %
Customer 211.3 %16.4 %
Customer 310.1 %4.1 %
Customer 45.8 %10.9 %

For the nine months ended and as of September 30, 2024
% of Revenue% of Accounts Receivable
Customer 128.1 %21.0 %
Customer 219.0 %23.7 %
Customer 312.4 %13.2 %